Sleep Apnea Clinical Trial
Official title:
Effect of Strength Training on Sleep Apnea in the Elderly
The objective of the study is to evaluate the impact of strength training on sleep apneas in the elderly. Individuals aged between 65 and 80 years and that presenting apnea-hypopnea index between 20 and 50 events per hour, measured by out-of-center portable polysomnography, will be recruited. Those included will be randomized to two groups: Intervention: consisted of 12 weeks, twice a week, of strength training; or control: consisted of lifestyle recommendations.
Obstructive sleep apnea (OSA) is a disorder that exposes the individual to repeated periods
of hypoxia and awakenings during sleep. OSA occurs in up to one third of the population,
constituting a public health problem. The prevalence of sleep apnea increases with age,
reaching up to 90%. Its consequences include sympathetic nervous system activation, increased
blood pressure and heart rate, myocardial contractility overload, decline in parasympathetic
activity, oxidative stress, systemic inflammation, platelet activation, and impaired vascular
endothelial function. OSA is a risk factor for hypertension, coronary artery disease,
peripheral artery disease, heart failure, and arrhythmias. The classical treatment options
for OSA are the use of continuous positive airway pressure, oral appliances for mandibular
advancement, surgery, weight reduction, and lifestyle change, including recommendation of
regular practice of exercise.
Physical exercise is accepted culturally and scientifically as a non-pharmacological
intervention beneficial to health. Aerobic and resistance exercises improve the quality of
sleep. There is evidence of improvement in the general well-being and, particularly in sleep.
Promote or improve sleep through exercise is healthy, safe, and simple. A sedentary lifestyle
is linked with a higher incidence and severity of sleep apnea. Increase in the number of
hours of exercise reduces these problems. Exercise has been used with consistent results to
treat OSA. The effect size of exercise in treatment of OSA ranges between 0.4 and 1.5
standard deviations. In a meta-analysis, totaling 129 participants, the mean effect was the
reduction of 7 events per hour. Although the results of randomized clinical trials and other
studies pointing to the decrease in AHI after physical training, all studies involved adult
populations with an average age between 42 and 54 years. The role of exercise in the elderly
with OSA, the most affected population, remains uninvestigated.
The research question is: What is the effect of strength training on the apnea-hypopnea index
(AHI) in elderly with OSA? The objective of the study is to evaluate the impact of strength
training on OSA in the elderly.
The trial will recruit individuals aged 65 to 80 years ascribed to a primary care unit linked
to the university hospital. Individuals that accept to participate in the study, will undergo
out-of-center polysomnography in order to detect and quantify the severity of OSA.
Individuals with AHI between 20 and 50 events per hour will be eligible, and will be randomly
allocated to the intervention or the control group. Randomization will be performed by
sequence numbers generated by computer at randomization.com.
Individuals allocated to the intervention group will hold two sessions per week of strength
training consisted of exercises for legs, arms, chest, back, and abdomen in the university
Physical Education High School, during 12 weeks. The individuals allocated to the control
group will receive advice on lifestyle and will participate in the meetings of an elderly
social group in the basic health unit. All individuals from both groups will perform an
evaluation consisting of body composition by bioelectrical impedance, maximum dynamic force
by 1-repetition maximum strength test, quality and muscle thickness by ultrasound, and
physical function by Sit-to-stand test, Timed up and go test and Handgrip strength test. All
evaluations will be repeated at the end of the 12-week period.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05582070 -
Effect on Sleep of Surgical Treatment of Severe Nasal Obstruction
|
N/A | |
Recruiting |
NCT03919955 -
A Novel Pharmacological Therapy for Obstructive Sleep Apnea
|
Phase 2 | |
Completed |
NCT03927547 -
Sleep Disordered Breathing and Cardiopulmonary Disease in Peruvian Highlanders
|
N/A | |
Recruiting |
NCT04007380 -
Psychosocial, Cognitive, and Behavioral Consequences of Sleep-disordered Breathing After SCI
|
N/A | |
Completed |
NCT02188498 -
Electrocardiography Data Analysis in Sleep Disorders
|
||
Completed |
NCT01503164 -
Effects of Continuous Positive Airway Pressure (CPAP) on Glucose Metabolism
|
N/A | |
Recruiting |
NCT00747890 -
Surgical Treatment of Mild Obstructive Sleep Apnea
|
N/A | |
Active, not recruiting |
NCT00738179 -
Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea to Prevent Cardiovascular Disease
|
Phase 3 | |
Completed |
NCT00841906 -
Alice PDx User/Validation Extended Trial
|
N/A | |
Completed |
NCT00202501 -
Usefulness of Nasal Continuous Positive Airway Pressure (CPAP) Treatment in Patients With a First Ever Stroke and Sleep Apnea Syndrome
|
N/A | |
Completed |
NCT00047463 -
Effects of Treating Obstructive Sleep Apnea in Epilepsy
|
Phase 2 | |
Not yet recruiting |
NCT06029881 -
Portable System for Non-intrusive Monitoring of Sleep
|
||
Recruiting |
NCT06093347 -
Central Apnoea Monitor Study
|
||
Terminated |
NCT05445869 -
Severe OSA Study (SOS)
|
N/A | |
Withdrawn |
NCT04096261 -
The Importance of Sleep Quality and the Blood-brain Barrier in Cognitive Disorders and Alzheimer's Disease
|
||
Recruiting |
NCT04575740 -
Phenotyping Mechanistic Pathways for Adverse Health Outcomes in Sleep Apnea
|
N/A | |
Completed |
NCT04676191 -
Validation of a Contactless Vital Signs Measurement Sensor
|
N/A | |
Recruiting |
NCT06015620 -
Comorbidities Resolution After MGB Surgery and Change in Body Composition
|
||
Completed |
NCT06051097 -
Metabolic Syndrome and Obstructive Sleep Apnea
|
||
Completed |
NCT05687097 -
Untreated Sleep Apnea as an Aggravating Factor for Other Secondary Medical Conditions After Spinal Cord Injury
|